🇺🇸 FDA
Pipeline program

Epinephrine

EPI-ESD RCT01

Phase 3 small_molecule completed

Quick answer

Epinephrine for Gastric Neoplasm is a Phase 3 program (small_molecule) at Chinese University of Hong Kong with 1 ClinicalTrials.gov record(s).

Program details

Company
Chinese University of Hong Kong
Indication
Gastric Neoplasm
Phase
Phase 3
Modality
small_molecule
Status
completed

Clinical trials